Results 51 to 60 of about 7,425 (188)
Endocrinology, Diabetes & Metabolism Case Reports, 2021 We observed a novel therapeutic response with cabergoline in a male patient with a dopamine-secreting head and neck paraganglioma (HNPGL), macroprolactinoma and germline succinate dehydrogenase C mutation (SDHC).
Ziad Hussein +3 more
doaj +1 more source
Acta Ophthalmologica, Volume 104, Issue 6, Page e630-e647, September 2026.Abstract Purpose To identify associations between systemic drugs and cataract surgery in Finland. Methods A historic cohort study based on administrative data. Endpoint event was cataract surgery. Use of drugs in question was based on redeemed prescriptions and consisted of 156 drugs.
Antti Riikonen +3 more
wiley +1 more source
, 2007 The effectiveness of cabergoline in 50 men with psychogenic erectile dysfunction was investigated in a 4-month, randomized, placebo-controlled, double-blind study with validated psychological tests, and prolactin, follicle-stimulating hormone ...
Loew, T +4 more
core +1 more source
Cabergoline treatment in acromegaly: pros [PDF]
, 2014 Cabergoline is an ergot-derived dopamine D2 receptor agonist which may be effective for the medical management of acromegaly. Its efficacy in reducing growth hormone and IGF-I levels, as well as its antiproliferative and pro-apoptotic effects on ...
Ramos-Levi, A +3 more
core +1 more source
Comparison of the effects of cabergoline and bromocriptine in women with hyperprolactinemic amenorrhea [PDF]
, 2008 Objective: There are relatively few reports in the world comparing the beneficial and adverse effects of bromocriptine and cabergoline in the treatment of hyperprolactinemic patients and there is also lack of such studies in Iraq.
Mahmood, Isam H. +2 more
core +1 more source
Journal of Dairy Science, 2023 : Drying off dairy cows may challenge animal welfare due to high milk yields. A total of 111 loose-housed Holstein cows yielding >15 kg/d of milk were included in a 2 × 2 × 2 factorial design during dry-off to investigate the effects of reduced feeding ...
Margit Bak Jensen +4 more
doaj +1 more source
Equine Veterinary Education, Volume 38, Issue 9, Page e622-e630, September 2026.Summary Background The diagnosis and management of pituitary pars intermedia dysfunction (PPID) in horses includes evaluating abnormal plasma concentrations of adrenocorticotrophic hormone (ACTH). Treatment commonly includes the oral dopamine agonist pergolide mesylate, which suppresses the pathologic overproduction of ACTH.
A. Bracken +5 more
wiley +1 more source
, 2002 Dopamine agonists have diverse chemical and physical properties that can directly stimulate the dopamine receptors, unlike levodopa which undergoes presynaptic breakdown to dopamine before dopaminergic effects in Parkinson's disease (PD).
Porter, M. C. +2 more
core +4 more sources
A fatal overdose of the ergot derivative cabergoline
, 2004 Cabergoline,Whole blood,Poisoning ...
Johansen, Sys Stybe +1 more
core +1 more source
Oral cabergoline for the management of equine pituitary pars intermedia dysfunction: Five cases
Open Veterinary JournalBackground: Oral pergolide has become the mainstay of treatment for equine pituitary pars intermedia dysfunction (PPID). It has a high success rate but some horses are, or become, refractory to the effects.
Eleanor M. Kellon
doaj +1 more source